Psilocybin: A New Horizon in the Treatment of Depression
In an effort to find alternatives to traditional treatments for depression, a recent study has put the spotlight on psilocybin, a psychedelic compound found in hallucinogenic mushrooms. Published in the medical journal BMJ, the study compared the efficacy of psilocybin with that of escitalopram, a selective serotonin reuptake inhibitor (SSRI) and one of the most commonly prescribed antidepressants. The Promise of Psychedelics SSRIs, such as escitalopram, have been a mainstay in the treatment of depression for decades.